查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1315705

動物分子診斷市場：按產品、技術、動物類型、適應症和最終用戶 - 全球預測 2023-2030

Veterinary Molecular Diagnostic Market by Product, Technology, Animal Type, Disease Indication, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球獸醫分子診斷市場預計到2023年將大幅成長至57,974萬美元，年複合成長率為9.15%，到2030年將達到10,7185萬美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球動物分子診斷市場至關重要。透過檢驗業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 動物分子診斷的全球市場規模與預測為何？

2.在預測期內，COVID-19對全球動物分子診斷市場的阻礙因素與影響為何？

3.在預測期內，全球動物分子診斷市場需要投資哪些產品/細分市場/應用/領域？

4.全球動物分子診斷市場的競爭策略為何？

5. 全球動物分子診斷市場的技術趨勢和法律規範是什麼？

6.全球獸用分子診斷市場主要廠商的市佔率是多少？

7. 哪些型態和策略措施被認為適合進入全球動物分子診斷市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 擁有的寵物和牲畜數量增加
      • 改善經濟區獸醫醫療設施
      • 動物慢性病發生率增加
    • 抑制因素
      • 與先進的分子診斷設備和檢測相關的高成本
    • 機會
      • 動物分子診斷技術進展
      • 擴大寵物保險的範圍
    • 任務
      • 缺乏熟練的專業人員
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 動物分子診斷市場：副產品

  • 設備和軟體
  • 試劑盒和試劑
  • 服務

第7章 動物分子診斷市場：依技術分類

  • DNA序列測定
  • 微陣列
  • 聚合酶鍊式反應

第8章 按動物類型分類的動物分子診斷市場

  • 伴侶動物
    • 犬科動物
    • 馬
    • 貓科動物
  • 家畜
    • 乳牛
    • 綿羊或山羊
    • 豬
    • 家禽

第9章 獸醫分子診斷市場：依疾病適應症

  • 腹瀉病原體檢測
  • 呼吸道病原體檢測
  • 媒介傳播疾病

第10章 獸醫分子診斷市場：依最終用戶分類

  • 醫院
  • 參考實驗室
  • 獸醫診所

第11章美洲獸醫分子診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太獸醫分子診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲獸醫分子診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第15章上市公司名單

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-034B50030398

The Global Veterinary Molecular Diagnostic Market is forecasted to grow significantly, with a projected USD 579.74 million in 2023 at a CAGR of 9.15% and expected to reach a staggering USD 1,071.85 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Veterinary Molecular Diagnostic Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Veterinary Molecular Diagnostic Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Instruments & Software, Kits & Reagent, and Services. The Services is projected to witness significant market share during forecast period.

Based on Technology, market is studied across DNA Sequencing, Microarrays, and Polymerase Chain Reaction. The Microarrays is projected to witness significant market share during forecast period.

Based on Animal Type, market is studied across Companion Animal and Livestock Animal. The Companion Animal is further studied across Canine, Equine, and Feline. The Livestock Animal is further studied across Bovine, Ovine or Caprine, Porcine, and Poultry. The Companion Animal is projected to witness significant market share during forecast period.

Based on Disease Indication, market is studied across Diarrhea Pathogens Detection, Respiratory Pathogens Detection, and Vector Borne Diseases. The Diarrhea Pathogens Detection is projected to witness significant market share during forecast period.

Based on End User, market is studied across Hospitals, Reference Laboratories, and Veternary Clinics. The Veternary Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Veterinary Molecular Diagnostic Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Veterinary Molecular Diagnostic Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Molecular Diagnostic Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Molecular Diagnostic Market?

4. What is the competitive strategic window for opportunities in the Global Veterinary Molecular Diagnostic Market?

5. What are the technology trends and regulatory frameworks in the Global Veterinary Molecular Diagnostic Market?

6. What is the market share of the leading vendors in the Global Veterinary Molecular Diagnostic Market?

7. What modes and strategic moves are considered suitable for entering the Global Veterinary Molecular Diagnostic Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Veterinary Molecular Diagnostic Market, by Product, 2022 vs 2030
  • 4.3. Veterinary Molecular Diagnostic Market, by Technology, 2022 vs 2030
  • 4.4. Veterinary Molecular Diagnostic Market, by Animal Type, 2022 vs 2030
  • 4.5. Veterinary Molecular Diagnostic Market, by Disease Indication, 2022 vs 2030
  • 4.6. Veterinary Molecular Diagnostic Market, by End User, 2022 vs 2030
  • 4.7. Veterinary Molecular Diagnostic Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing number of companion animal and livestock ownership
      • 5.1.1.2. Improving veterinary care facilities in economies
      • 5.1.1.3. Rising incidence of chronic diseases in animals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with sophisticated molecular diagnostics instruments and assays
    • 5.1.3. Opportunities
      • 5.1.3.1. Advances in veterinary molecular diagnostic technology
      • 5.1.3.2. Growing availability of pet insurance
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Veterinary Molecular Diagnostic Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments & Software
  • 6.3. Kits & Reagent
  • 6.4. Services

7. Veterinary Molecular Diagnostic Market, by Technology

  • 7.1. Introduction
  • 7.2. DNA Sequencing
  • 7.3. Microarrays
  • 7.4. Polymerase Chain Reaction

8. Veterinary Molecular Diagnostic Market, by Animal Type

  • 8.1. Introduction
  • 8.2. Companion Animal
    • 8.2.1. Canine
    • 8.2.2. Equine
    • 8.2.3. Feline
  • 8.3. Livestock Animal
    • 8.3.1. Bovine
    • 8.3.2. Ovine or Caprine
    • 8.3.3. Porcine
    • 8.3.4. Poultry

9. Veterinary Molecular Diagnostic Market, by Disease Indication

  • 9.1. Introduction
  • 9.2. Diarrhea Pathogens Detection
  • 9.3. Respiratory Pathogens Detection
  • 9.4. Vector Borne Diseases

10. Veterinary Molecular Diagnostic Market, by End User

  • 10.1. Introduction
  • 10.2. Hospitals
  • 10.3. Reference Laboratories
  • 10.4. Veternary Clinics

11. Americas Veterinary Molecular Diagnostic Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Veterinary Molecular Diagnostic Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Veterinary Molecular Diagnostic Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET RESEARCH PROCESS
  • FIGURE 2. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2022 VS 2030
  • FIGURE 3. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2030 (%)
  • FIGURE 7. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2030 (%)
  • FIGURE 8. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 9. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. VETERINARY MOLECULAR DIAGNOSTIC MARKET DYNAMICS
  • FIGURE 11. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. VETERINARY MOLECULAR DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. VETERINARY MOLECULAR DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. VETERINARY MOLECULAR DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY KITS & REAGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 9. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 14. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 19. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY OVINE OR CAPRINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DIARRHEA PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY RESPIRATORY PATHOGENS DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VECTOR BORNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY VETERNARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK ANIMAL, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES VETERINARY MOLECULAR DIAGNOSTI